210 related articles for article (PubMed ID: 33191244)
1. Effect of paroxetine on intestinal motility in the presence of ondansetron.
Afzal A; Khan A; Khan A; Farooqi R; Khan BT; Ara I
Pak J Pharm Sci; 2020 May; 33(3):1169-1172. PubMed ID: 33191244
[TBL] [Abstract][Full Text] [Related]
2. Paroxetine: An update of response on intestinal motility.
Afzal A; Ajmal K; Shakir S; Khan BT; Ara I
J Pak Med Assoc; 2016 Mar; 66(3):240-2. PubMed ID: 26968268
[TBL] [Abstract][Full Text] [Related]
3. Ondansetron: A newer aspect of dose response relationship on ileal smooth muscles of rabbit.
Afzal A; Khan BT; Bakhtiar S
Pak J Pharm Sci; 2016 Jan; 29(1):119-24. PubMed ID: 26826825
[TBL] [Abstract][Full Text] [Related]
4. Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study.
Mir O; Durand JP; Boudou-Rouquette P; Giroux J; Coriat R; Cessot A; Ropert S; Goldwasser F; Gaillard R
Support Care Cancer; 2012 Sep; 20(9):2235-9. PubMed ID: 22644261
[TBL] [Abstract][Full Text] [Related]
5. [The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Kind B; Fattinger K; Krähenbühl S; Meier-Abt PJ
Praxis (Bern 1994); 1996 Nov; 85(46):1490-2. PubMed ID: 8984572
[TBL] [Abstract][Full Text] [Related]
6. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility.
Feinle C; Read NW
Am J Physiol; 1996 Oct; 271(4 Pt 1):G591-7. PubMed ID: 8897877
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting.
Cubeddu LX; Hoffmann IS; Fuenmayor NT; Finn AL
N Engl J Med; 1990 Mar; 322(12):810-6. PubMed ID: 1689807
[TBL] [Abstract][Full Text] [Related]
9. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
Gregory RE; Ettinger DS
Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
[TBL] [Abstract][Full Text] [Related]
10. [An outline of 5-HT3 receptor antagonists (1)--In pharmacological actions].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Nov; 20(14):2108-14. PubMed ID: 8239673
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron. Therapeutic use as an antiemetic.
Milne RJ; Heel RC
Drugs; 1991 Apr; 41(4):574-95. PubMed ID: 1711961
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.
Wilde MI; Markham A
Drugs; 1996 Nov; 52(5):773-94. PubMed ID: 9118822
[TBL] [Abstract][Full Text] [Related]
13. Management of chemotherapy-related nausea and vomiting using a serotonin antagonist.
Egan AP; Taggart JR; Bender CM
Oncol Nurs Forum; 1992 Jun; 19(5):791-5. PubMed ID: 1535124
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
Redrobe JP; Bourin M; Colombel MC; Baker GB
J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
[TBL] [Abstract][Full Text] [Related]
15. GYKI-46 903, a non-competitive antagonist for 5-HT3 receptors.
Csillik-Perczel V; Bakonyi A; Yemane T; Vitalis B; Horvath E; Solyom S; Szekely JI; Harsing LG
Pharmacol Toxicol; 1996 Jul; 79(1):32-9. PubMed ID: 8841094
[TBL] [Abstract][Full Text] [Related]
16. 5-HT3 receptors, nausea, and serotonin reuptake inhibition.
Coupland NJ; Bailey JE; Potokar JP; Nutt DJ
J Clin Psychopharmacol; 1997 Apr; 17(2):142-3. PubMed ID: 10950495
[No Abstract] [Full Text] [Related]
17. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
[TBL] [Abstract][Full Text] [Related]
18. Effects of fluvoxamine, a selective serotonin re-uptake inhibitor, on serotonin release from the mouse isolated ileum.
Minami M; Taguchi S; Kikuchi T; Endo T; Hamaue N; Hiroshige T; Liu Y; Yue W; Hirafuji M
Res Commun Mol Pathol Pharmacol; 2003; 113-114():115-31. PubMed ID: 15686112
[TBL] [Abstract][Full Text] [Related]
19. Effect of 5-hydroxytryptamine on gastrointestinal motility in conscious guinea-pigs.
Nakajima M; Shiihara Y; Shiba Y; Sano I; Sakai T; Mizumoto A; Itoh Z
Neurogastroenterol Motil; 1997 Dec; 9(4):205-14. PubMed ID: 9430788
[TBL] [Abstract][Full Text] [Related]
20. Ondansetron facilitates neuromuscular transmission in the guinea-pig ileum.
González AA; Puig MM
Eur J Pharmacol; 1997 Jun; 328(2-3):201-6. PubMed ID: 9218702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
